Saturday, February 21, 2015 1:35:06 PM
In the big picture (i.e. getting the Propanc Drug line FDA approved and to the market) the increase in authorized stock may be what Propanc needs to raise additional capital to fund their Clinical Trials and it will certainly attract additional investors. I sincerely hope that PPCH investors expand way beyond us few at investorshub. Sure, the pps might drop in the short term, but in terms of PPCH making it to the market place, this may be what they need to do, which in the end, is good if you're patient and hold on.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM